AHA 2019: GALILEO Trial Suggests No Benefit for Routine Anticoagulation Following Transcatheter Aortic Valve Replacement
Mortality was greater in the rivaroxaban-treated arm
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.